Lark Distilling Co. Ltd (LRK)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 0.730 |
|---|---|
| 52-week range | 0.560 – 0.945 |
| Return, 1 month / 3 months | −12.0% / −17.5% |
| Return, 1 year / 3 years | −5.2% / −48.4% |
| Trend | Below its 200-day average |
| RSI (14) | 18 |
| Volatility (1 year) | 35.6% |
| Worst drawdown (1 year) | -25.7% |
| Average daily value traded | 0.03M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lark Distilling Co. Ltd is a Tasmanian spirits producer based in Hobart. The company makes single malt whisky at its own distillery, along with gin and other spirits, using locally sourced barley and water. Its customers include drinkers who buy bottles through retailers, bars and restaurants, and it also sells to overseas markets. The business grew out of a small craft distillery and continues to focus on Tasmanian-made whisky and related spirits.
On this site Lark Distilling Co. Ltd appears as a stock on the Australian Securities Exchange (Australia), code LRK, with prices in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lark Distilling Co. Ltd (LRK) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.730 on 19 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 556 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.2% and over the last three months it fell 17.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -8.9% | ||
| From 52-week high | -21.1% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.5% | ||
| 6-month return | -17.5% | ||
| 12-month return, skipping the last month | 7.8% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.7% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M AUD | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −8.8% |
|---|---|
| 1 month | −12.0% |
| 3 months | −17.5% |
| 6 months | −17.5% |
| 1 year | −5.2% |
| 3 years | −48.4% |
| 5 years | −86.5% |
Signals
| 50-day / 200-day average | 0.840 / 0.801 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.024 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.